Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice

[1]  Xj Wang,et al.  Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp−/− mice , 2012, Gene Therapy.

[2]  C. Cho,et al.  Protective effects of cathelicidin‐encoding Lactococcus lactis in murine ulcerative colitis , 2012, Journal of gastroenterology and hepatology.

[3]  W. Vilegas,et al.  Effect of Byrsonima crassa and Phenolic Constituents on Helicobacter pylori-Induced Neutrophils Oxidative Burst , 2011, International journal of molecular sciences.

[4]  P. Janmey,et al.  Cathelicidin LL-37 Increases Lung Epithelial Cell Stiffness, Decreases Transepithelial Permeability, and Prevents Epithelial Invasion by Pseudomonas aeruginosa , 2011, The Journal of Immunology.

[5]  T. A. Nagy,et al.  Helicobacter pylori induction of eosinophil migration is mediated by the cag pathogenicity island via microbial-epithelial interactions. , 2011, The American journal of pathology.

[6]  斉藤 明生.  Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia , 2011 .

[7]  B. Strukelj,et al.  Engineered Lactic Acid Bacterium Lactococcus lactis Capable of Binding Antibodies and Tumor Necrosis Factor Alpha , 2010, Applied and Environmental Microbiology.

[8]  W. Wu,et al.  Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disorders , 2010, Acta Pharmacologica Sinica.

[9]  Min Jun Song,et al.  The Effect of Probiotics and Mucoprotective Agents on PPI‐Based Triple Therapy for Eradication of Helicobacter pylori , 2010, Helicobacter.

[10]  L. Bermúdez-Humarán.  Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins , 2009, Human vaccines.

[11]  J. Kong,et al.  Identification of Nisin-Producing Strains by Nisin-Controlled Gene Expression System , 2009, Current Microbiology.

[12]  G. Nair,et al.  Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.

[13]  R. Sleator,et al.  Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract , 2008, BMC Microbiology.

[14]  N. Van Rooijen,et al.  Macrophages Are Mediators of Gastritis in Acute Helicobacter pylori Infection in C57BL/6 Mice , 2008, Infection and Immunity.

[15]  E. El-Omar,et al.  Host-bacterial interactions in Helicobacter pylori infection. , 2008, Gastroenterology.

[16]  T. Wang,et al.  Protective role of 17 beta -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. , 2007, Carcinogenesis.

[17]  M. McGuckin,et al.  Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. , 2007, Gastroenterology.

[18]  W. Wu,et al.  A New Role for Cathelicidin in Ulcerative Colitis in Mice , 2007, Experimental biology and medicine.

[19]  C. Josenhans,et al.  Helicobacter pylori evolution and phenotypic diversification in a changing host , 2007, Nature Reviews Microbiology.

[20]  W. H. So,et al.  The Cationic Host Defense Peptide rCRAMP Promotes Gastric Ulcer Healing in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[21]  T. Hökfelt,et al.  The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection , 2006, Nature Medicine.

[22]  Xuxia Zhou,et al.  The nisin-controlled gene expression system: construction, application and improvements. , 2006, Biotechnology advances.

[23]  M. Gotteland,et al.  Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? , 2006, Alimentary pharmacology & therapeutics.

[24]  Michiel Kleerebezem,et al.  10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis , 2005, Applied Microbiology and Biotechnology.

[25]  C. Mein,et al.  Evaluation of DNA extraction methods from mouse stomachs for the quantification of H. pylori by real-time PCR. , 2005, Journal of microbiological methods.

[26]  R. Gallo,et al.  Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. , 2005, The Journal of investigative dermatology.

[27]  E. Smid,et al.  Optimization of the Lactococcus lactis nisin-controlled gene expression system NICE for industrial applications , 2005, Microbial cell factories.

[28]  M. Kagnoff,et al.  Cathelicidin Mediates Innate Intestinal Defense against Colonization with Epithelial Adherent Bacterial Pathogens1 , 2005, The Journal of Immunology.

[29]  S. Falkow,et al.  Chronic Helicobacter pylori Infection with Sydney Strain 1 and a Newly Identified Mouse-Adapted Strain (Sydney Strain 2000) in C57BL/6 and BALB/c Mice , 2004, Infection and Immunity.

[30]  Kevin F. Jones,et al.  Mucosal Vaccine Made from Live, Recombinant Lactococcus lactis Protects Mice against Pharyngeal Infection with Streptococcus pyogenes , 2004, Infection and Immunity.

[31]  D. Sgouras,et al.  In Vitro and In Vivo Inhibition of Helicobacter pylori by Lactobacillus casei Strain Shirota , 2004, Applied and Environmental Microbiology.

[32]  Satoru Takahashi,et al.  Effects of Cytokines, Without and with Helicobacter pylori Components, on Mucus Secretion by Cultured Gastric Epithelial Cells , 1998, Digestive Diseases and Sciences.

[33]  Konturek Jw.  Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer. , 2003 .

[34]  M. Kagnoff,et al.  Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. , 2003, Gastroenterology.

[35]  J. Konturek.  Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer. , 2003, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[36]  J. J. Kim,et al.  Long-term Stress and Helicobacter pylori Infection Independently Induce Gastric Mucosal Lesions in C57BL/6 Mice , 2002, Scandinavian journal of gastroenterology.

[37]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[38]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[39]  M. Stoffel,et al.  Distinction of Gastric Helicobacter spp. in Humans and Domestic Pets by Scanning Electron Microscopy , 2000, Helicobacter.

[40]  J. Everhart.  Recent developments in the epidemiology of Helicobacter pylori. , 2000, Gastroenterology clinics of North America.

[41]  R. Bals,et al.  The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Atherton,et al.  H. pylori virulence factors. , 1998, British medical bulletin.

[43]  M F Dixon,et al.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. , 1997, Gastroenterology.

[44]  Y. Yamaoka,et al.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. , 1996, Gastroenterology.

[45]  M. Blaser,et al.  Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. , 1996, Advances in internal medicine.

[46]  I. Nes,et al.  High-Frequency Transformation, by Electroporation, of Lactococcus lactis subsp. cremoris Grown with Glycine in Osmotically Stabilized Media , 1989, Applied and environmental microbiology.

[47]  C. Woese,et al.  Sequence of the 16S Ribosomal RNA from Halobacterium volcanii, an Archaebacterium , 1983, Science.

[48]  J Robinwarren,et al.  UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983 .

[49]  C R Woese,et al.  Classification of methanogenic bacteria by 16S ribosomal RNA characterization. , 1977, Proceedings of the National Academy of Sciences of the United States of America.